Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. - Wikidata - awgldk - TriplyDB

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

http://www.wikidata.org/entity/Q51710821

about

Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus The pathogenicity of the Streptococcus genus A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013.Invasion of endothelial cells by tissue-invasive M3 type group A streptococci requires Src kinase and activation of Rac1 by a phosphatidylinositol 3-kinase-independent mechanism.Contribution of exogenous genetic elements to the group A Streptococcus metagenome Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.Differences in SpeB protease activity among group A streptococci associated with superficial, invasive, and autoimmune disease.Molecular epidemiology of sil locus in clinical Streptococcus pyogenes strains.Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002).Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.Streptococcus pyogenes Phospholipase A2 Induces the Expression of Adhesion Molecules on Human Umbilical Vein Endothelial Cells and Aorta of Mice.Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003 Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis Srv mediated dispersal of streptococcal biofilms through SpeB is observed in CovRS+ strains Risk for severe group A streptococcal disease among patients' household contacts.Managing toxic shock syndrome with antibiotics.Molecular epidemiologic comparison of 2 unusual clusters of group a streptococcal necrotizing fasciitis in Hawaii.Characterization of a community cluster of group a streptococcal invasive disease in Maui, Hawaii Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation The small regulatory RNA FasX enhances group A Streptococcus virulence and inhibits pilus expression via serotype-specific targets.Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence.Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong Liver cirrhosis as a real risk factor for necrotising fasciitis: a three-year population-based follow-up study.Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315.M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2.Group A streptococcal bacteremia without a source is associated with less severe disease in children

P2860

Q22066388-EFABB158-2713-4247-B03F-F8DE11BADB48 Q24600416-327E7C95-6506-4162-BF20-D7C7A2BB3FB9 Q24672693-341333FD-2C12-43F4-87BA-7F226CA3F7D7 Q27005596-46CD2575-2EF8-47DF-B2C4-FC83EDCE5F84 Q30202103-4DE82E36-CDDA-4FBA-95BE-C309B4DC3F93 Q30490061-9C8095DB-71C4-43A1-9A22-FA668DAEC872 Q33295386-590E8A60-3F62-4BE5-A786-276B13C78927 Q33627302-1C2A639D-9AE6-4D0F-BC7E-F9672E3C26B1 Q33642062-E212EDC1-F4C7-403A-AE07-847C4DBE4B40 Q33674247-BF3159A0-95A0-48D7-9702-31D52BA7FD87 Q33699090-0AF1C9AB-70D1-47B8-BE21-BF9769F9B632 Q33703624-EA75FB72-9246-4727-8D37-4A58566E5C34 Q33753208-CD5A97AA-7E2B-4984-B612-3A5C5085319B Q33753352-E8811634-D2F4-4BFB-A754-19C79EA7FD4A Q33753390-7442981E-67BD-42F4-9463-50F827EDEF92 Q33788220-BC7F5571-FB4E-46E1-93E0-75B67174A889 Q33824679-98B838B1-02CE-42FE-AD2B-5406B4504C6D Q33855328-71E37F4F-0608-49E7-B315-2E54B9873BA3 Q33877781-E7ACBDA9-F86A-46C0-8536-188D804B9308 Q33884965-0C24939D-BB63-4EC3-B843-2EFA730FD2D5 Q33910815-51EA62D4-71D4-45E2-85F1-14FDAD0814DD Q34041494-E11B3C50-EC06-4A0E-98C5-26ADAA0A2154 Q34098283-21425024-EE8B-4C2F-B048-62C2F17CCC6F Q34216043-06A0A465-DA48-4B42-A6DA-E4FAD2A7B022 Q34334680-1A3C1E15-8979-49AD-8CBE-3C3F959FB6B6 Q34345145-FFACB3FA-31EE-4949-988E-6842F4C3588F Q34345153-14CE260D-2960-453C-A2D4-C4ABDF181AC6 Q34413457-97348932-A4E0-43B0-9BEA-D05CBA5A5216 Q34437647-1E2A40E2-FD0B-43B1-B152-C4B9F101B2CB Q34458113-E3648AA3-371B-4F53-94B7-A2B6C9537C29 Q34487628-C7163657-1DAB-4C59-B1B7-9AA840343E78 Q34699741-15DB08CE-9AE1-4AD8-80A3-4461BC289015 Q34721159-6737DE83-BD2A-4E7E-81E0-6C13ECE5723F Q34774612-B8D1A64F-C40B-4FE4-830C-7CFD4C4A42DF Q34929134-62DFB919-2C3D-410B-9EBD-AA5CC2D32576 Q34943643-6F4F0228-BE7E-43FD-AA4E-342689B19D43 Q34990045-07ED44CD-3BE9-469F-B5BB-76CA890D57D4 Q35094453-03AAA8EA-5ADD-449B-B472-E391EB80E55B Q35127605-06D2BF1E-F7BD-4EDD-A700-6753B69638E1 Q35171156-D697271A-5CE1-4C1A-B0ED-0F66EFF427AB

P2860

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

http://www.wikidata.org/entity/Q51710821

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@en

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@nl

type

label

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@en

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@nl

prefLabel

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@en

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@nl

P1433

Q51710821-5297785C-42E2-4BEB-A91B-4791E95432B0

P1476

Q51710821-B76EC815-E6C0-4697-8433-F1D1F5062368

P2093

Q51710821-291A33F3-54E6-4D38-B63F-7B911A77CC32

Q51710821-2F4EA9E6-3017-42E7-A9A0-3C045EFF3EE1

Q51710821-3ECD2806-3577-46F6-B918-CB110D1B61FD

Q51710821-434AA494-D0A1-41EB-A400-E2754C3F8467

Q51710821-48BDC8FA-45F0-4E42-A0C5-5E508A66B13A

Q51710821-720D1F38-856E-4844-8334-FF10D73A1C87

Q51710821-A38D5977-424D-4F33-81C6-E3CD5E433F0E

Q51710821-CCE46409-A7B5-4752-B1FB-A9576FDB462F

Q51710821-D44CEFA7-BAB5-47F1-9A88-968611AE9330

P2860

Q51710821-0B507F71-B88E-4286-A6B1-E22A719A7671

Q51710821-1207FA3D-1A2B-40EA-8DF4-975FCD63E2AC

Q51710821-19F3983E-117F-4917-9A46-8D4ABB8B9314

Q51710821-1D6CDE60-73CE-4D8A-8C2C-65EE22287A3E

Q51710821-22403231-5C9A-42E1-9296-DE0739A74AA9

Q51710821-22F127D3-8835-4CAE-9651-E6FB37DFE6F1

Q51710821-24522966-D924-4C89-8701-29F4810A94D6

Q51710821-2E876A6D-4F4A-4BA2-8E11-29B4A42D0EDA

Q51710821-319FB2DA-5FBF-4BB7-8CD1-48FD60C90170

Q51710821-3E635272-A6AF-4031-9E77-4AA0449A0B8E

P304

Q51710821-F5F512EE-1604-48E5-9A5C-245F37E90695

P31

Q51710821-D5C6A83B-6C5D-4403-B600-144DFD9127CB

P356

Q51710821-0969E640-AEE9-4F52-80D2-8C82C4DFBE83

P407

Q51710821-F4B7CCC3-EDA3-416E-BB72-60810AE93657

P433

Q51710821-82EAA693-32AF-4F3B-A9F4-F32B4062E895

P478

Q51710821-878A25E7-0936-4C38-80C5-AA7F4D4A1F37

P50

Q51710821-56559689-9B45-4107-BCF3-58A9C2887D16

Q51710821-A4BF9A40-B344-47E0-94E6-294FC05EA2B9

P577

Q51710821-BA078F71-4CDE-4BE3-B3A1-028201DCC89B

P5875

Q51710821-0AB4A177-3460-444B-A37C-8B85F1FEFCEA

P698

Q51710821-E4B8626B-DED2-4AF0-BE8A-2523D108157E

P921

Q51710821-3DBC22AA-CC94-44C9-A95E-0033CF2C5ECF

Q51710821-BB3C0185-23A0-4C06-BD61-217D36D9745B

P356

P1433

Clinical Infectious Diseases

P1476

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

@en

P2093

Arthur Reingold

http://www.w3.org/2001/XMLSchema#string

Benjamin Schwartz

http://www.w3.org/2001/XMLSchema#string

Bernard Beall

http://www.w3.org/2001/XMLSchema#string

Elizabeth R Zell

http://www.w3.org/2001/XMLSchema#string

Monica M Farley

http://www.w3.org/2001/XMLSchema#string

Nancy L Barrett

http://www.w3.org/2001/XMLSchema#string

Paul R Cieslak

http://www.w3.org/2001/XMLSchema#string

Richard Danila

http://www.w3.org/2001/XMLSchema#string

Richard Facklam

http://www.w3.org/2001/XMLSchema#string

P2860

Streptococcal M protein: molecular design and biological behavior.

Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.

Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Invasive group A streptococcus infections.

Changes in the pattern of infection caused by Streptococcus pyogenes.

emm typing and validation of provisional M types for group A streptococci.

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

Acute rheumatic fever in New York City (1969 to 1988): a comparative study of two decades.

Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment.

P304

268-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/341409

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11263813

http://www.w3.org/2001/XMLSchema#string

P698

12115092

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq